AltPep
AltPep develops early detection tools and disease-modifying treatments for amyloid diseases, including neurodegenerative conditions and type 2 diabetes, by targeting toxic soluble oligomers. Its lead program focuses on identifying Alzheimer’s disease before symptoms appear and neutralizing the associated toxic oligomers. The organization aims to enable early screening and preventive intervention for these diseases.
Facts
- HQ
- Seattle, WA
- Sectors
- Biotechnology
- Founded
- 2019
- Type
- Corporation Seattle business license
- Employees
- 32
- Registered name
- AltPep Corporation Seattle business license
- Stage
- Series B
- Members see funding amounts. .
Is this your organization? Claim it
Founders
-
Valerie Daggett Executive Officer, Director, Promoter, Founder and CEO